Opportunities in the Biotechnology Industry

Paper Summary:

This paper focuses on the biotech industry which is currently controlled by several big global companies and the fact that this is about to change. Patents on nearly $40 billion in drugs manufactured by the large pharmaceutical companies are set to expire which should open the door for smaller companies to help medicate the world. The writer's vision is for smaller companies to secure a place in an international growth market, to receive approval by various government agencies, to prove the efficacy of innovations and more importantly to solve some of the world's ills which can be alleviated by biotechnological products. This paper includes a statistical graph detailing biotech industry threats and opportunities.
Topics covered in this report include:
Vision Statement
Mission Statement
Competition
Political
Ecological
Energy
Economic
Spirit/Ethics
International
Technology
Social
Conclusions and Statistics About Threats and Opportunities for a New Venture
Citations

From the Paper:

"As long as there is no human genome project underway, there is little government interference. However, the American companies claim that the FDA is much too slow, compared to overseas regulatory agencies, to approve new drugs. For this reason, many of the companies are either buying, being bought by, or creating partnerships with overseas companies in order to sell their drugs where restrictions are not as tight as in the U.S. One major problem that the industry faces is the high cost to the consumer. Congress has a number of bills about medical costs."

More papers on Opportunities in the Biotechnology Industry:

• Research Paper # 118688 : "Biotech Opportunities in India"
• Analytical Essay # 118832 : "Biotech Opportunities in India"
• Essay # 48563 : "Biotechnology Industry"

APA Citation:

MLA Citation: